• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMR 1.85% 82.5¢

IMRICOR MEDICAL SYSTEMS INC. - Charts / Financials

Imricor Medical Systems, Inc. is a developer of magnetic resonance imaging... Imricor Medical Systems, Inc. is a developer of magnetic resonance imaging (MRI)-compatible medical devices, which is used to carry out real-time interventional Cardiac Magnetic Resonance Imaging (iCMR) cardiac ablation procedures. The Company is engaged in designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include Vision-mitral regurgitation (MR) Ablation Catheter, Advantage-MR electrophysiology (EP) Recorder/Stimulator and Vision-MR Dispersive Electrode. The Vision-MR Ablation Catheter is designed to work under real-time MRI guidance. Advantage-MR EP Recorder/Stimulator System provides technology that allows physicians to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. The Company sells its products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

refresh Created with Sketch. REFRESH
Last update - 14.57pm 18/11/2024 (20 minute delay) ?
Day
Open 82.5¢   Day High 85.0¢   Day Low 82.5¢
Daily Volume 117095
Bids   Sellers
Number Price Volume   Number Price Volume
1 82.0¢ 3500   1 82.5¢ 5113

Directors & Senior Management

Mr. Steve Wedan Executive Chairman of the Board, President, Chief Executive Officer
Mr. Jonathon Gut Chief Financial Officer, Vice President - Finance
Mr. Gregg Stenzel Chief Operating Officer
Mr. Vic Fabano Vice President - Operations
Mr. Nick Twohy Vice President of Marketing
Mr. Dan Sunnarborg Vice President - Engineering
Ms. Jennifer Weisz Vice President - Regulatory and Quality
Mr. Greg Englehardt Executive Director of Sales
Mr. Thomas Worgul Director of Sales Europe
Ms. Kate Lindborg Director of Clinical Affairs
Mr. Mark Tibbles Non-Executive Deputy Chairman of the Board, Lead Independent Director
Mr. Jeffrey Leighton Director
Mr. Peter McGregor Non-Executive Director
Ms. Anita Messal Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
82.5¢
Change
0.015(1.85%)
Mkt cap ! $141.8M
Open High Low Value Volume
82.5¢ 85.0¢ 82.5¢ $97.73K 117.0K

Buyers (Bids)

No. Vol. Price($)
1 3500 82.0¢
 

Sellers (Offers)

Price($) Vol. No.
82.5¢ 5113 1
View Market Depth
Last trade - 16.10pm 18/11/2024 (20 minute delay) ?
Last
83.0¢
  Change
0.015 ( 0.01 %)
Open High Low Volume
83.0¢ 85.0¢ 83.0¢ 4789
Last updated 14.57pm 18/11/2024 ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.